CERILLIANT™ Brivaracetam-D3 Solution, 100 μg/mL in Methanol, Sold by MilliporeSigma™ Supelco™
Certified reference material
Manufacturer: MilliporeSigma Supelco B0631ML
DescriptionAn internal standard suitable for GC/MS or LC/MS applications in brivaracetam testing from clinical toxicology and forensic analysis to urine drug testing and isotope dilution methods. Brivaracetam is an antiepileptic drug for the treatment of partial-onset seizures. The drug is marketed under the trade name Briviact™.
|9.7°C (49.5°F) - closed cup|
|100 μg/mL in methanol|
|UN 1230 - class 3 - PG 2 - Methanol, solution|
Safety and Handling
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok
CERILLIANT is a registered trademark of Cerilliant Corporation